Cite
Marchesi F, Pimpinelli F, Giannarelli D, et al. Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin's lymphomas. Leukemia. 2021;doi: 10.1038/s41375-021-01418-8.
Marchesi, F., Pimpinelli, F., Giannarelli, D., Ronchetti, L., Papa, E., Falcucci, P., Pontone, M., Di Domenico, E. G., di Martino, S., Laquintana, V., Mandoj, C., Conti, L., Cordone, I., La Malfa, A., Viggiani, C., Renzi, D., Palombi, F., Romano, A., Pisani, F., Gumenyuk, S., Di Bella, O., Vujovic, B., Morrone, A., Ciliberto, G., Ensoli, F., & Mengarelli, A. (2021). Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin's lymphomas. Leukemia, . https://doi.org/10.1038/s41375-021-01418-8
Marchesi, Francesco, et al. "Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin's lymphomas." Leukemia vol. (2021). doi: https://doi.org/10.1038/s41375-021-01418-8
Marchesi F, Pimpinelli F, Giannarelli D, Ronchetti L, Papa E, Falcucci P, Pontone M, Di Domenico EG, di Martino S, Laquintana V, Mandoj C, Conti L, Cordone I, La Malfa A, Viggiani C, Renzi D, Palombi F, Romano A, Pisani F, Gumenyuk S, Di Bella O, Vujovic B, Morrone A, Ciliberto G, Ensoli F, Mengarelli A. Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin's lymphomas. Leukemia. 2021 Sep 20; doi: 10.1038/s41375-021-01418-8. Epub 2021 Sep 20. PMID: 34545184; PMCID: PMC8451738.
Copy
Download .nbib